Hypoalbuminemia in COVID-19: assessing the hypothesis for underlying pulmonary capillary leakage.
M A WuT FossaliL PandolfiL CarsanaD OttolinaV FrangipaneR RechA TosoniG LopezA AgarossiC CogliatiF MeloniB MarchiniM NebuloniE CatenaRiccardo ColomboPublished in: Journal of internal medicine (2021)
Hypoalbuminaemia may serve as severity marker of epithelial-endothelial damage in patients with COVID-19. There are clues that pulmonary capillary leak syndrome plays a key role in the pathogenesis of COVID-19 and might be a potential therapeutic target.